 | Up a level |
Heimann, S., Cornely, O., Wisplinghoff, H., Vehreschild, M., Franke, B. and Vehreschild, J. (2015). A Disease Cost Analysis of Clostridium difficile associated Diarrhea from the Perspective of the German Health System. Internist, 56. S. 57 - 59. NEW YORK: SPRINGER. ISSN 1432-1289
Heimann, S., Cornely, O., Wisplinghoff, H., Vehreschild, M., Franke, B. and Vehreschild, J. (2015). A Disease Cost Analysis of Clostridium difficile associated Diarrhea from the Perspective of the German Health System. Internist, 56. S. 57 - 59. NEW YORK: SPRINGER. ISSN 1432-1289
Heimann, S., Cornely, O. A., Meintker, L., Heinz, W., Schroeder, T., Vehreschild, M., Wisplinghoff, H., von Bergwelt-Baildon, M. and Vehreschild, J. (2014). Different Doses of Micafungin for Prophylaxis of Invasive Fungal Diseases: A Web-based Non-Interventional Trial in Four Large University Hospitals in Germany. Oncol. Res. Treat., 37. S. 121 - 122. BASEL: KARGER. ISSN 2296-5262
Heimann, S., Cornely, O. A., Wisplinghoff, H., Vehreschild, M. J., Franke, B., Glossmann, J. and Vehreschild, J. (2012). COST-OF-ILLNESS ANALYSIS OF CANDIDEMIA IN PATIENTS ON THE INTENSIVE CARE UNIT. Value Health, 15 (7). S. A390 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1098-3015
Heimann, S., Cornely, O. A., Wisplinghoff, H., Vehreschild, M. J., Franke, B., Glossmann, J. and Vehreschild, J. (2012). DEVELOPMENT OF TREATMENT COSTS OF PATIENTS UNDERGOING REMISSION INDUCTION CHEMOTHERAPY: A HISTORICAL COMPARISON BEFORE AND AFTER INTRODUCTION OF POSACONAZOLE PROPHYLAXIS. Value Health, 15 (7). S. A391 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1098-3015